![Stuart Gunzburg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 362 039 $ al 30/06/2026
Stuart Gunzburg is the founder of Nextract Pty Ltd. Dr. Gunzburg is currently Managing Director & Director at Metavone Ltd. Dr. Gunzburg is also Executive Director & Chief Scientific Officer at EVE Health Group Ltd., starting in 2025.
Dr. Gunzburg holds an MBA and a doctorate from The University of Western Australia.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EVE HEALTH GROUP LIMITED 7,81 % | 20/03/2026 | 27.510.581 ( 7,81 % ) | 362 039 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EVE HEALTH GROUP LIMITED | Director Técnico/Científico/I+D | 12/06/2025 |
Metavone Ltd.
 Metavone Ltd. BiotechnologyHealth Technology Discovers and develops therapeutic treatments for dementia and hormone related cancers | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
EVE Health Group Ltd.
 EVE Health Group Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and retails health and wellness food products | Health Technology |
The University of Western Australia
 The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Metavone Ltd.
Metavone Ltd. BiotechnologyHealth Technology Discovers and develops therapeutic treatments for dementia and hormone related cancers | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
